Key Legislative Changes in Pharmaceuticals and Healthcare in Q3 2026

What legislative changes affected the pharmaceutical and healthcare sectors in Belarus and at the EAEU level in Q3 2026?In its latest overview, REVERA highlights the key legislative developments relevant to manufacturers and distributors of medicinal products and medical devices, healthcare organisations and other Life Science market participants.

The overview covers changes in GMP requirements, the registration of medicinal products and medical devices, advertising, charitable activities in healthcare, public procurement and other relevant areas.

Download the full REVERA overview to review the key developments and assess their potential impact on your business.

Contacts:

Sergey Sushchena
s.sushchenua@revera.legal

Denis Valyukevich
d.valukevich@revera.legal

Irina Navitskaya
i.navitskaya@revera.legal